# Hans Wedel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hans-wedel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 74,778 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 103 |
| i10-index | 250 |
| OpenAlex ID | https://openalex.org/A5005456371 |
| ORCID iD | 0000-0001-7571-0021 |
| Works | 343 |

## Researcher papers

Showing 12 of 23.

- [Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial](https://scholariq.org/papers/effects-of-intensive-blood-pressure-lowering-and-low-dose-aspirin-in-patients/)
- [Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol](https://scholariq.org/papers/cardiovascular-morbidity-and-mortality-in-the-losartan-intervention-for-endpoint/)
- [Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects](https://scholariq.org/papers/effects-of-bariatric-surgery-on-mortality-in-swedish-obese-subjects/)
- [Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery](https://scholariq.org/papers/lifestyle-diabetes-and-cardiovascular-risk-factors-10-years-after-bariatric/)
- [Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial](https://scholariq.org/papers/prevention-of-coronary-and-stroke-events-with-atorvastatin-in-hypertensive/)
- [Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures](https://scholariq.org/papers/meta-analysis-of-how-well-measures-of-bone-mineral-density-predict-occurrence-of/)
- [Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial](https://scholariq.org/papers/prevention-of-cardiovascular-events-with-an-antihypertensive-regimen-of/)
- [Bariatric Surgery and Long-term Cardiovascular Events](https://scholariq.org/papers/bariatric-surgery-and-long-term-cardiovascular-events/)
- [Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year](https://scholariq.org/papers/randomized-trial-of-insulin-glucose-infusion-followed-by-subcutaneous-insulin/)
- [Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol](https://scholariq.org/papers/cardiovascular-morbidity-and-mortality-in-patients-with-diabetes-in-the-losartan/)
- [Rosuvastatin in Older Patients with Systolic Heart Failure](https://scholariq.org/papers/rosuvastatin-in-older-patients-with-systolic-heart-failure/)
- [Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure](https://scholariq.org/papers/effects-of-controlled-release-metoprolol-on-total-mortality-hospitalizations-and/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.